Archive

Archive for the ‘NASDAQ: IMUC.OB’ Category

ImmunoCellular Therapeutics (IMUC.OB) to present at 2nd World Cancer Vaccines Summit

June 22nd, 2011 No comments

IMUC.OB’s President and CEO Manish Singh PhD will present at the 2nd World Cancer Vaccines Summit Read more…

ImmunoCellular Therapeutics (IMUC.OB) issued Cancer Vaccine Technology Patent

June 21st, 2011 No comments

OTCBB: IMUC has been issued a US patent relating to a technology for the treatment of cancer Read more…

ImmunoCellular Therapeutics (IMUC.OB) New Data from PI Glioblastoma Multiforme Trial at ASCO

May 24th, 2011 No comments

100% of Patients in Study express at least 3 Antigens targeted By ICT-107; validating positive correlation between targeting stem cells and survival Read more…